Therefore, on the basis of this innovative mechanism, we discovered that TBM-2 exhibits a remarkable inhibitory effect on cell viability in hepatocellular carcinoma (HCC), both in vitro and in vivo, advancing it as a highly promising candidate for future application in HCC management. Here, MUC5AC is linked to hepatocellular carcinoma.